Bayer Statement on Final Brief Regarding the Petition for Writ of Certiorari in Hardeman
Bayer today issued the following statement on its final brief regarding its Petition for a Writ of Certiorari in Hardeman.
May 23, 2022
Bayer today issued the following statement on its final brief regarding its Petition for a Writ of Certiorari in Hardeman.
Bayer today issued the following statement on the Solicitor General’s Amicus Brief in the Hardeman appeal.
The Washington Legal Foundation filed an amicus brief in support of Monsanto’s petition to the Supreme Court for review of the Pilliod decision.
Today Monsanto filed a petition for certiorari with the U.S. Supreme Court in its appeal of the Pilliod verdict. Bayer’s statement on the filing is as follows.
Bayer today released the following statement on the defense verdict in Stephens.
Today, Monsanto filed its reply brief to the Supreme Court in support of its petition for review of the Hardeman decision.
Bayer today released the following statement on the verdict in the Clark trial in the Superior Court of California, County of Los Angeles.
Several organizations have filed amici briefs in support of Monsanto’s petition to the Supreme Court for review of the Hardeman decision.
On September 20, 2021, Monsanto filed a petition for review of the Pilliod decision with the California Supreme Court.
On June 4, 2021, Monsanto filed its appellee brief in the Carson appeal in the U.S. Court of Appeals for the 11th Circuit.
Bayer today provided an update on its five-point plan to address future Roundup™ litigation risk after its May 27th decision to withdraw from the national class process. The company is now in more control of important aspects of the risk mitigation process and has sketched out two basic scenarios going forward to provide a path to closure of this litigation. The first scenario is based on obtaining a favorable decision by the United States Supreme Court on a cross-cutting issue like federal preemption which would effectively and largely end the U.S. Roundup™ litigation. The second scenario assumes that the Supreme Court either declines to hear the Hardeman case or issues a ruling in favor of plaintiff – in that case the company would activate its own claims administration program.
Read about the five-point plan here.